Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S2001 |
---|---|
Cancer Type: | Metastatic Pancreatic |
Fast Facts |
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations.
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A212102 |
---|---|
Cancer Type: | Early Detection Blood Tests |
Fast Facts |
Blinded Reference Set for Multicancer Early Detection Blood Tests
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1801 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1501 CC cardiac tox |
---|---|
Cancer Type: | METASTATIC HER-2+ BREAST CANCER |
Fast Facts |
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III
Protocol | SWOG S1703 |
---|---|
Cancer Type: | METASTATIC BREAST CANCER |
Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
Protocol | URCC 16070 CC nausea |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Treatment of Refractory Nausea
Protocol | SWOG S1904 |
---|---|
Cancer Type: | ATYPICAL HYPERPLASIA OR LOBULAR CARCINOMA IN SITU |
Fast Facts |
CLUSTER RANDOMIZED CONTROLLED TRIAL OF PATIENT AND PROVIDER DECISION SUPPORT TO INCREASE CHEMOPREVENTION INFORMED CHOICE AMONG WOMEN WITH
ATYPICAL HYPERPLASIA OR LOBULAR CARCINOMA IN SITU - MAKING INFORMED CHOICES ON INCORPORATING CHEMOPREVENTION INTO CARE (MiCHOICE)
Protocol | Alliance A191901 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S0820 |
---|---|
Cancer Type: | Colorectal |
Fast Facts |
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Protocol | WF 1806 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
Protocol | Alliance A221805 |
---|---|
Cancer Type: | CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY |
Fast Facts |
DULOXETINE TO PREVENT OXALIPLATIN-INDUCED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TO PHASE III STUDY
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1802 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAQ172 |
---|---|
Cancer Type: | Pneumonitis |
Fast Facts |
Optimizing Immunosuppression for Steroid-Refractory Anti-PD-1/PD-L1 Pneumonitis
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A211901 |
---|---|
Cancer Type: | Rural Cancer Survivors |
Fast Facts |
REACHING RURAL CANCER SURVIVORS WHO SMOKE USING TEXT-BASED CESSATION INTERVENTIONS
Protocol | URCC 18007 |
---|---|
Cancer Type: | Cancer-Related Fatigue |
Fast Facts |
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue
Protocol | URCC 21038 |
---|---|
Cancer Type: | Cancer Survivors |
Fast Facts |
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1151 (TMIST) |
---|---|
Cancer Type: | Screening |
Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Protocol | EA2185 |
---|---|
Cancer Type: | Pancreatic Cyst Surveillance |
Fast Facts |
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
Protocol | DCP-001 |
---|---|
Cancer Type: | Multisite - Screening |
Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Protocol | NRG CC005 FORTE |
---|---|
Cancer Type: | Colonoscopy |
Fast Facts |
FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | COG ALTE03N1 |
---|---|
Cancer Type: | Multi-site Cancer Control |
Fast Facts |
Key Adverse Events After Childhood Cancer
Diagnosis of Primary Cancer at Age 21 or Younger, Irrespective of Current Age.
Protocol | COG ALTE07C1 |
---|---|
Cancer Type: | Multi-Site Cancer Control |
Fast Facts |
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.